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PABPStress granules (SGs) are ribonucleoprotein (RNP)-containing assemblies that are formed in the cytoplasm in
response to stress. Previously, we demonstrated that microtubule depolymerization inhibited SG formation.
Here, we show that arsenate-induced SGs move throughout the cytoplasm in a microtubule-dependent
manner, and microtubules are required for SG disassembly, but not for SG persistence. Analysis of SG
movement revealed that SGs exhibited obstructed diffusion on an average, though sometimes SGs
demonstrated rapid displacements. Microtubule depolymerization did not inﬂuence preformed SG number
and size, but signiﬁcantly reduced the average velocity of SG movement, the frequency of quick movement
events, and the apparent diffusion coefﬁcient of SGs. Actin ﬁlament disruption had no effect on the SG
motility. In cycloheximide-treated cells SGs dissociated into constituent parts that then dissolved within the
cytoplasm. Microtubule depolymerization inhibited cycloheximide-induced SG disassembly. However,
microtubule depolymerization did not inﬂuence the dynamics of poly(A)-binding protein (PABP) in SGs,
according to FRAP results. We suggest that the increase of SG size is facilitated by the transport of smaller SGs
along microtubules with subsequent fusion of them. At least some protein components of SGs can exchange
with the cytoplasmic pool independently of microtubules.Nadezhdina),
ll rights reserved.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Stress granules (SGs) are formed in eukaryotic cells in response to
acute stress conditions, such as oxidative stress, UV irradiation, and heat
shock [1–3]. SGs are dense particles ranging from about 1 µm to several
microns in size. SGs accumulate components of the 48S pre-initiatory
complexes (mRNAs, small ribosomal subunits, eIF3, eIF4F), a number of
proteins involved in the regulation of RNA functions [1,4–7], and some
cell regulatory proteins which can be sequestered speciﬁcally to SGs
[8,9]. SGs assemble when translation initiation is repressed. Often, but
not always, such inhibition is induced by eIF2a phosphorylation [1,4].
SGs do not contain 60S ribosomal subunits, and mRNAs in SGs are not
translated. Presumably, SGs temporarily store mRNA and ensure its
sorting between translation and degradation pathways [7]. The small
ribosomal subunits andmRNA shuttle between SGs and polysomes, and
inhibition of translation elongation, for example with cycloheximide
(Chx) treatment, “freezes” polysomes and induces the dissociation of
SGs [10].
SGs are dynamic structures; they form within minutes of stress
application and dissolve within a few hours of stress recovery, orwithin an hour under Chx treatment [10]. Therefore, the whole life
cycle of SGs includes assembly, persistence and disassembly.
Fluorescence recovery after photobleaching (FRAP) studies indicate
that most of SG components exchange with the cytoplasmic pool
rather rapidly, with a half-recovery time of 5–60 s [9–14], except the
slowly recovering FMRP [12], FAST [11] and RSK2 (in serum-starved
cells) [9] proteins. It was recently shown that protein modiﬁcation
with O-linked N-acetylglucosamine in response to stress is important
for SG assembly [15]. However, signals involved in SG assembly and
disassembly are still unknown. Heat shock proteins rather facilitate SG
disassembly than congregation [16]. SGs contain plenty of proteins
[1,5,7,12–20], and few of them are essential for SG formation. It also
remains unclear whether SGs have a core structural scaffold and
periphery or whether they are homogeneous particles.
The highly dynamic nature of SG components might indicate their
active transport in the cytoplasm. Indeed, SG formation depends on
the dynamic microtubule system and is affected after microtubule
disruption [20–22]. However, it is still unclear whether microtubules
serve as tracks for the active delivery of SG components. Experiments
on Drosophila oocytes, nerve cells, and ﬁbroblasts demonstrate that at
least some mRNAs are actively transported through the cytoplasm
along microtubules [23]. For long-distance transport in neuron
extensions, mRNAs gather in large aggregates (transport granules)
containing translation components such as small ribosomal subunits.
These mRNAs are not translated during transport [24–26], though
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bound to adaptor RNA-binding proteins such as CPEB or FMRP, which
also interact with the microtubule-dependent motor proteins, kinesin
and dynein [25,27]. Dynein light chains have been shown to bind
some mRNAs directly by recognizing certain UTR sequences [28].
Perhaps mRNP can be delivered to SGs by microtubule-dependent
motors along microtubule tracks. However, actin ﬁlaments might also
serve as tracks for the transport of translation components, though
this question has not been carefully studied yet.
Another type of RNA-containing granule is the processing body (P-
body) which contains mRNAs and components of the mRNA 5′–3′
decaymachinery [6,11,29–31]. P-bodies have been hypothesized to be
sites of mRNA degradation, mRNA translational control, and/ormRNA
storage. They are conserved from yeast to mammals and contain a
common set of evolutionarily conserved protein constituents. P-
bodies are dynamic structures and their formation appears to
ﬂuctuate in correlation with alterations in mRNA metabolism [31].
During stress, P-bodies can transiently associate with SGs [11,30].
They vary in size and number, being usually smaller than SGs and less
numerous. P-bodies move chaotically in the cytoplasm, and their
movement is inhibited by microtubule depolymerization [30,31].
Active transport could probably facilitate the association of P-bodies
with SGs. However, microtubule disruption in yeast led to the
accumulation of bona ﬁde P-bodies [31].
We suggest that if SG constituents are actively delivered to SGs
along microtubules, these constituents can stay unloaded from
motors after delivery and SGs can continue to move after their
formation while remaining bound to the motors. Indeed, SG motility
itself has beenmentioned in some papers but has not been thoroughly
studied. In this work, we address questions whether SG motility
occurred by active transport, whether the movement is tracked by
microtubules or actin, whether SG persistence and disassembly
depends on microtubules, and whether the exchange of SG compo-
nents depends on their active intracellular transport.
2. Materials and methods
2.1. DNA constructs and antibodies
Human cytoplasmic poly(A)-binding protein (PABPC-1, PABP
hereinafter) full-length cDNA (MGC-15290) and human TIA-1 full-
length cDNA (ATCC#7483776) were purchased from the American
True Type Culture Collection. The coding regions were ampliﬁed with
PCR and cloned using the TOPO TA cloning kit (Invitrogen) into the
pCR 2.1-TOPO vector. PABP cDNA was subcloned into the pEGFP-C1
and pmCherry-C1 vectors (Clontech) with BamHI and SalI. TIA-1 was
subcloned into the pEGFP-C1 vector (Clontech) with EcoRI and SalI.
The EGFP-tubulin plasmid was obtained from Evrogen.
The following primary antibodies were purchased: mouse mono-
clonal anti-TIA-1 (Abcam), anti-tubulin DM1A (Sigma), and anti-PABP
(Abcam). Rabbit polyclonal anti-eIF3a antibody has been described
previously [32]. Rabbit polyclonal anti-phospho-eIF2a antibody was
purchased from Cell Signaling. Goat-derived IgG-speciﬁc secondary
antibodies conjugated to FITC or TRITC were obtained from Jackson
ImmunoResearch.
Western blot with anti-phospho-eIF2a antibody was performed as
described previously [20].
2.2. Cell culturing, transfection, and treatments
Human HeLa cells and green monkey CV-1 cells were grown in
DMEM/F-12 medium (Paneco), and Chinese hamster CHO cells were
grown in F10 medium (Paneco). For all cultures, the medium was
supplemented with 10% newborn bovine serum (HyClone) and
antibiotics. Cells were grown at 37 °C and 5% CO2. Transfection was
performedwith Lipofectamine2000 (Invitrogen) or TransIT-LT1reagent(Mirus) according to the manufacturers' instructions. Treatment of the
cells with drugs and subsequent live video imagingwere performed the
day after transfection. For live cell imaging, the culture medium was
supplemented with oxyrase (Oxyrase).
To induce SGs, cells were incubated with 2 mM sodium arsenate
(Na2HAsO4) for the indicated time at 37 °C. Chx treatment (10 μg/ml)
was performed for 1h at 37 ºC. For microtubule depolymerization, cells
were incubated on ice bath for 1h, and then nocodazole (6 μg/ml) was
added for 30 min at 37 °C. For the control of cold action, cells were
incubated on ice bath for 1h, and then at 37 °C for 30 min (cold-
warming treatment). For microtubule stabilization, 10 μg/ml of pacli-
taxel (taxol) (Sigma) was added for 30 min. For actin ﬁlament
disassembly cells were treated with 0.5 µg/ml latrunculin A (Calbio-
chem) for 30 min at 37 °C. If cells were ﬁrst treated with arsenate
followed by Chx in the same media, the treatment is referred to as
“arsenate–Chx”. Arsenate-taxol, arsenate-latrunculin etc. treatments
were performed in the sameway, i.e., arsenatewas addedﬁrst, and then
the other drug was introduced to the same medium. All experiments
were repeated in triplicate.
2.3. Immunoﬂuorescent microscopy and live cell imaging
Three different protocolswere used for cellﬁxation. According to the
ﬁrst protocol, cellswere extractedwith absolutemethanol for 10 min at
−20 °C, post-ﬁxed in 3% formaldehyde/PBS for 15 min at 4 °C, and
permeabilized for 10 min with 0.1% Triton X-100 in PBS. According to
the second protocol, cells were extracted with absolute methanol for
10 min at−20 °C and washed in PBS. According to the third protocol,
cells were ﬁxed in 3% formaldehyde/PBS for 15 min at room
temperature, and permeabilized for 10 min with 0.1% Triton X-100 in
PBS. After ﬁxation, cells were either immunostained or stained with
FITC-phalloidin (Alexis) to visualize F-actin andDAPI to visualize nuclei.
The third protocol of ﬁxation was used for experiments with FITC-
phalloidin staining only.
Observations were made with the Axiovert 2000 M (Carl Zeiss)
microscope using 63× and 100× Plan-NEOFLUAR objectives. Images
were acquired with AxioVision 3.1 software (Carl Zeiss Vision) using
the AxioCamHRc digital video camera (Carl Zeiss) and processed with
Photoshop V. 8.0 (Adobe Systems). A temperature-controlled stage
and a 100 W halogen light source were used for live cell imaging.
Images were captured every 2–20s for 1–10 min.
FRAP analysis and dual channel confocal imagingwere performed on
the LSM 510 inverted confocal laser scanning microscope system (Carl
Zeiss) using a 100× Plan-NEOFLUAR objective (numerical aperture 1.3)
and a temperature-controlled stage. An argon ion laser (488 nm) was
used to generate excitation lines. Selected SGs were photobleached for
6s at~0.5 mWusinga0.7 μmbeam. Fluorescenceemissionwasdetected
at 530±15 nm. Images were captured before bleaching and every 2s
after bleaching for 240s with a Zeiss AxioCam HRc digital video camera
driven by Zeiss LSM 510 Expert Mode software (Carl Zeiss Vision).
2.4. Quantitative image analysis
Time-lapse image data were stored as 16-bit digital ﬁles and
processed with MetaMorph software (Universal Imaging). SGs were
tracked using the Point-Tracking application of MetaMorph. The data
were imported into Excel for calculations of instantaneous velocity. A
self-written program was used to calculate and plot the mean square
displacement (MSD) versus time interval (τ), according to [33–35].
MSD was calculated for each particle and time point of the data set as
MSDðnτÞ = 1
N−n∑
N−n
i = 1½ðxðði + nÞτÞ−xðiτÞÞ2 + ðyðði + nÞτÞ−yðiτÞÞ2
The results were represented as bMSD(nτ)N (μm2) versus Δτ (s)
using Excel, with regression curve ﬁtting functions (trend line, Power
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coefﬁcient Dapp=MSD(nτ)/Δτ versus Δτ, accordingly to [36].
For SG quantization and for visited area projection calculations, the
video frames were ﬁrst normalized with the Bleaching Normalization
plug-in from ImageJ. Normalized stacks were binarized with the same
threshold for each frame. The number of SGs and total area of SG
projections were measured with the Region Measurements and
Integrated morphometry analysis applications in MetaMorph and
with ImageJ Analyse Particles plug-in.
FRAP time-series were analyzed with MetaMorph. Raw ﬂuores-
cence intensity data were ﬁrst adjusted by background subtraction at
each time point. The ﬂuorescence signal of 2–3 unbleached granules
in the same cell was averaged for each time point. The intensity of
each recovering granule was normalized to this signal, and the data
were plotted with Origin software (OriginLab Corp.).
3. Results
3.1. SGs move in cytoplasm, fuse and split
We examined a time course of SG formation by live cell imaging of
GFP-PABP-expressing HeLa cells. We found that numerous, small,
GFP-PABP-containing granules – SGs – emerged in the cytoplasm 3–
4min after arsenate application. The small SGs moved throughout the
cytoplasm, touched each other, and fused (Fig. 1A, Video S1). The
number of SGs per cell increased until 5–7 min of arsenate treatment
since SGs gradually rise in the cytoplasm. Subsequently, the number
of SGs decreased (pb0.01) and remained almost constant after 10–
12 min (Fig. 1B and data not shown). It seems that the decrease in SG
number was a result of SG fusion thus we did not observe any SG
disassembly events at this early period of arsenate treatment. The
movement of SGs was detectable as they formed.
Even at 150 min after arsenate application most GFP-PABP-
containing SGs continued to move chaotically in the cytoplasm
(Fig. 1C and Video S2). No signiﬁcant difference was found between
SG mobility in cold-warming treated and untreated cells (data not
shown). Occasionally, SGs moved very rapidly for long distances
(Fig. 1D and Video S3), resembling the saltatory leaps of membrane
vesicles described previously in a number of works [37]. At the same
time, other SGs did not move and, instead, exhibited only small
conﬁned movements or even were stationary. Many SGs chaotically
rambled in the cytoplasm (Fig. 1C). We also observed the events of SG
fusion: sometimes SGs touched each other, fused, and continued
moving as a single aggregate (Fig. 1D, Video S4). This can explain the
clustered structures and how they form.
We decided to study SG disassembly by live cell imaging. GFP-
PABP-expressing HeLa cells were ﬁrst treated with arsenate, and after
30 min, Chx was added for another 30 min, and SGs were observed by
time-lapse video microscopy. During SG disassembly they divided
into smaller particles, which moved away. It looked like small
particles were torn away by a pulling force (Fig. 1E, Videos S5, S6).
The pieces of SGs dissolved in the cytoplasm, the ﬂuorescence
intensity of SGs gradually diminished, and they looked as open-
work (Fig. 1E). We never observed SG splitting without Chx
treatment.
To conﬁrm that the effects described above were not speciﬁc for
GFP-PABP expression in HeLa, we analyzed SGs in living and ﬁxed
HeLa, CV-1, and CHO cells. To visualize SGs, we used GFP-PABP,
mCherry-PABP and GFP-TIA-1 expression and immunostaining with
anti-eIF3a and anti-PABP antibodies. We preferred these markers
because it has been previously shown that PABP and eIF3a proteins
are incorporated into SGs, but are absent from PBs [7]. TIA-1 protein
marks SGs though its accumulation in some PBs had already been
speculated [7]. In our experiments GFP-PABP, mCherry-PABP, GFP-
TIA-1, eIF3a and endogenous TIA/TIAR proteins were pretty co-
localized in arsenate-induced SGs (Fig. 2A, B and data not shown).This co-localization was conﬁrmed for HeLa cells having about 20–25
SGs and CV-1 cells having about 100 SGs (Fig. 2A, B and data not
shown). Live imaging of GFP-TIA-1-expressing arsenate-treated HeLa
cells revealed a continuous chaotic movement of SGs in the cytoplasm
similar to those of GFP-PABP-marked SGs (Fig. 2C, Video S7). We
suggested that SG mobility was not a result of GFP-PABP expression
and represented intrinsic feature of SGs.
3.2. Mobility of SGs is rather diffusive, and SGs scan the cytoplasm
We focused on the characterization of SG mobility. First of all, we
measured the instantaneous velocity of SG movement (calculated at
2–3 s intervals). Twelve cells were studied, and 75 SGs at 6524 time
intervals were tracked. We found that SGs were stationary for about
10% of the observation time (Fig. 3). The velocity of 8% of SGs was
above 0.2 μm/s (Fig. 3), the threshold usually preset for the
determination of directed, active movement. The highest SG velocity
was 0.7 μm/s and the average velocity (excluding stationary SGs) was
approximately 0.1 μm/s (Fig. 3). We did not ﬁnd signiﬁcant
dependence of SG velocity on their size (data not shown).
SG tracks captured during 3 min of observation were highly
variable (Fig. 4A, B). Among them, typical tracks of conﬁned, diffusing,
and directionally moving particles could be found (Fig. 4B), accord-
ingly to [33–35]. By dynamic MSD analysis we established that within
100 s of observation about 10% SGs demonstrated directional
movement, 17% — simple diffusion and 73% — obstructed diffusion.
Conﬁned particles were found in cells with altered microtubules only
(see below in Section 3.4). We calculated the average MSD value. The
resulting MSD vs. Δτ curve ﬁtted the obstructed diffusion (Fig. 4B, C).
The average apparent diffusion coefﬁcient, Dapp, decreased with time
(Fig. 3B), however, at large time intervals it converged to the
asymptotic value of Dapp as 1.9×10−3μm2/s.
To better describe the character of SG mobility, we measured the
area visited by SGs for certain time intervals. We measured the total
square of SG projections in the ﬁrst frame of time-lapse video. Then
we merged time-lapse frames and measured the total square of
merged SG projections. These merged projections are the cytoplasm
areas visited by SGs. After that, we estimated the ratio of SG projection
in a single frame and in merged frames. This ratio was plotted versus
time (Fig. 5).We found that SGs visited an area three times larger than
themselves for 4 min (Fig. 5). Presumably, SGs could accumulate all of
the appropriate components, such as smaller SGs, from visited area.
3.3. SGs associate with microtubules, and move along them
The dense and chaotic system of microtubules in HeLa cells did not
allow for an experimental comparison of SG tracks with microtubules.
Therefore, we examined CHO cells with a distinct radial system of
microtubules. The morphology and distribution of SGs in HeLa and
CHO cells were similar. We treated mCherry-PABP and GFP-tubulin
expressing CHO cells with arsenate and observed SGs and micro-
tubules in living cells by dual channel ﬂuorescent microscopy. We
revealed that moving SGs moved along microtubule tracks (Fig. 6A,
Video S8). In agreement with observations described above (in
Section 3.2) the mobility of SGs was unsteady: they moved, stopped,
moved in opposite direction etc. (Fig. 6A). SGs remained associated
with microtubules during both movements and pauses.
SGs were co-localized with microtubules in ﬁxed (accordingly to
ﬁrst and second protocols, see Section 2.3) and immunostained for
endogenous tubulin and SG markers cells (Figs. 2C; 6B, C). SGs always
had a contact with microtubules. After arsenate-taxol treatment (see
Section 2.2), in the stabilized microtubule network (data not shown
and Fig. 1E), SGs were also co-localized with microtubules (Fig. 6B).
We revealed that in arsenate-treated CV-1 and HeLa cells ﬁxed
with absolute methanol (accordingly to protocol 2, see Section 2.3)
and stained with anti-eIF3a antibodies, SGs resembled clusters and
Fig. 1. Stress granulesmove in cytoplasm, fuse and split. Pictures of live HeLa cells expressing GFP-PABP. (A) Dynamics of SG formation under arsenate treatment (frames fromVideo S1).
Time after arsenate application is indicated. Bar=5 μm. (B) The plot of average number of SGs after arsenate application. (C) SG movement in cell cytoplasm at 150 min after arsenate
application (frames fromVideo S2). The cellswere incubatedwith arsenate 1h at 37 °C, then subjected to cold-warming as described in Section 2.2. Elapsed timemin:s. Tracks of some SGs
are shown in the rightmostpicture. Bar=5 μm.(D)Examples of SGsaltatorymovement (upperpanel) and fusion (lowerpanel) (frames fromVideoS3andS4, correspondingly). Cellswere
treated with arsenate for 45 min. Elapsed time is indicated. Arrowheads point to SGs. Bar=1 μm. (E) Dynamics of dissolution of arsenate-induced SGs (30 min of arsenate) under Chx
treatment (frames fromVideo S5). The elapsed time is indicated, and zero time is 15 min after Chx addition. The splitting of SGs andmovement of SG fragments are shown in detail in the
right panel. Arrowhead points to SG fragment. Left panel: bar=5 μm. Right panel: bar=1 μm.
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shown). SGs themselves were quite variable in size, from approxi-
mately 200 nm (single particle size) to more than 5 μm. Clustered
structure of SGswas visible also inmCherry-PABP expressing cells and
less apparent in formalin-ﬁxed cells or in living cells expressing GFP-
PABP. This is most likely because of signiﬁcant cytosolic background of
soluble SG components (Fig. 1C, D).
If cells were treated with arsenate–nocodazole (see Section 2.2),
their microtubules were completely disrupted (Fig. 6A). Surprisingly,
the size and number of the SGs did not change, and the number of
cells containing SGs even increased (Figs. 7A,D; 8D). It indicates that
microtubules are not required for SG persistence. SGs in arsenate–
nocodazole treated cells could be visualized with GFP-PABP expres-sion (Fig. 7A), and with anti-TIA-1 and anti-eIF3a immunostaining
(Fig. S1), thus, they contained all main SG markers. Nocodazole
treatment slightly inﬂuenced SG distribution in cells: they looked
more scattered. To conﬁrm SG scattering, we measured and averaged
GFP-PABP ﬂuorescence intensity along cell radii (from cell periphery
to nucleus) in either arsenate or arsenate–nocodazole treated cells
(Fig. 7C). We revealed that in arsenate-treated cells SGs concentrated
in proximity to nuclei. After arsenate–nocodazole treatment, the
distribution of SGs was much more random (Fig. 7C). It seems that SG
accumulation in perinuclear area depends on microtubules.
Double labeling revealed that eIF3a-containing SGs did not co-
localize with actin stress ﬁbers in the cells. Most SGs accumulated in
areas with a low density of F-actin stress ﬁbers, andwere absent in the
Fig. 2. GFP-PABP, GFP-TIA and eIF3a are equal markers of SGs. (A) Arsenate-treated (as described in the legend for Fig. 1C) HeLa cell with double expression of GFP-TIA andmCherry-
PABP. Note co-localization of both markers in SGs. Bar=5 μm. (B) Movement of SGs in HeLa cell expressing GFP-TIA (frames from Video S6). Cells were treated with Ars as described
in the legend for Fig. 1C. Elapsed time is indicated. The rightmost picture is the imposition of three color-coded frames. Bar=5 μm. (C) GFP-PABP-expressing CV-1 cells were double
immunostained with anti-eIF3a and anti-tubulin antibodies after arsenate treatment. Note co-localization of eIF3a and GFP-PABP in SGs, and association of SGs with microtubules.
Bar=5 μm.
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with arsenate–latrunculin A displayed eIF3-containing SGs accumu-
lated in the perinuclear region, and multiple cytoplasmic foci of
aggregated actin. Obviously, these actin foci did not co-localize with
SGs (Fig. 7A). Latrunculin A treatment did not inﬂuence the number of
cells containing SGs (Fig. 7D) and number and size of SGs (data not
shown).
3.4. The analysis of SG movement: an active participation of microtubules
After disruption of microtubules with nocodazole the movement
of SGs was dramatically inhibited (Figs. 3–5, 7B, Video S9). Thirty-
seven SGs at 4234 time intervals from 4 cells were tracked inarsenate–nocodazole treated cells. We never observed sudden leaps
or any other large displacements of SGs. A few SGs (1.5%) moved with
a velocity above 0.2 μm/s (Fig. 4), and the mean velocity was
decreased to 0.076 μm/s (pb0.01) (Fig. 3). By MSD analysis, about
3% of SGs demonstrated conﬁned diffusion, 92% — obstructed
diffusion and 5% — simple diffusion. No directionally moving SGs
were identiﬁed. The average MSD/Δτ curve ﬁtted to an obstructed
diffusion, the same as in arsenate-treated cells (Fig. 4C). However, the
apparent diffusion coefﬁcient Dapp was more than three times
decreased to ~6×10−4μm2/s (Fig. 4D).
To examine the role of microtubule dynamics in SG motility, we
stabilized microtubules in arsenate-treated cells with taxol. The
movement of 64 SGs from 4 cells at 4689 time intervals was tracked.
Fig. 3. Velocity of SGmovement measured in 2–3 s intervals: histogram and average plot.
Ars — arsenate, Ars-Noc — arsenate–nocodazole, Ars-Tax — arsenate–taxol, Ars-Lat —
arsenate–latrunculin A treatments (see Section 2.2 for a detailed description of
treatments). In the average plot, the small squares inside the boxes indicate mean values,
transverse lines indicatemedians, boxes indicate the 25–75% percentile, andwhisker lines
indicate the 5–95% percentile.
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movement by only 6% (pb0.01) (Fig. 3). Among all SGs, 5% were
conﬁned, 62% demonstrated obstructed diffusion, 10% — simple
diffusion and 22% demonstrated directed motion. These data are easy
to explain if SGsmove alongmicrotubules in dense network: sometimes
they can be caught with the network, but it is effortless to them to ﬁndFig. 4. The analysis of diffusive movement of SGs. (A) Examples of typical SG tracks per 90 s. d
diffusion. (B) The plot of MSD for SGs whose tracks are shown in (A). (C) The plot of averag
nocodazole, Ars-Tax — arsenate–taxol, Ars-Lat — arsenate–latrunculin A (see Section 2.2 for d
experimental condition. Straight black lines indicate asymptotes for each curve.microtubule and move. The Dapp/Δτ curve for arsenate-taxol treated
cells did not reach asymptotic values for the time of observation, and
Dapp was estimated approximately as 1.2×10–3μm2/s.
Latrunculin A causes the disruption of actin ﬁlaments and should
inhibit any myosin-dependent transportation of SGs along actin
ﬁlaments. However, latrunculin A did not inhibit SGmobility, but even
increased it to some extent. Nineteen SGs from 3 cells at 2360 time
intervals were tracked. The number of SGs moving with a velocity
above 0.2 μm/s was also slightly increased (Fig. 3), and the number of
stationary granules was slightly reduced (Fig. 3). In comparison with
arsenate-treated cells, the average velocity of SGs was increased by 5%
(p=0.026). The MSDav/Δτ and Dapp/Δτ curves coincided with that of
the control (Fig. 4C, D).
In arsenate-latrunculin A treated cells, the scanning of cytoplasm
with SGs was almost the same as in arsenate-treated ones (Fig. 5).
However, arsenate and arsenate–nocodazole treated cells were
signiﬁcantly different in cytoplasm scanning of their SGs (Fig. 5).
For 4 min SGs in arsenate–nocodazole treated cells visited an area one
and a half larger than their own projection area only (Fig. 5). In cells
with taxol-stabilized microtubules, SGs barely reached an area two-
fold larger than themselves (Fig. 5). Thus, all aspects of SG motility
were dependent on microtubules, and not on actin ﬁlaments.3.5. SG disassembly depends on microtubules
The SG life cycle includes assembly, persistence and disassembly.
We showed that SG assembly depends on microtubules, though
persistence does not. Next we examined the role of the microtubule
system in SG disassembly. Arsenate–Chx treatment (see Section 2.2
for details) caused SG disassembly within approximately 1 h in cells
with intact microtubules (Fig. 8A, B, D). The average number of SGs.m.— directed motion; s.d.— simple diffusion; o.d.— obstructed diffusion; c.d.— conﬁned
e MSD of cell SGs for each experimental condition: Ars — arsenate, Ars-Noc — arsenate–
etailed description). (D) The plot of apparent diffusion coefﬁcient (Dapp) of SGs for each
Fig. 5. SGs scan the cytoplasm. HeLa cells expressing GFP-PABP are shown. Green— projections of SGs at the ﬁrst time frame of stack. Red— summary of SG projections in stack (240 s
total). Bar=5 μm. D — Plot of ratio of merged SG projections and single frame SG projections. Ars — arsenate, Ars-Noc — arsenate–nocodazole, Ars-Tax — arsenate–taxol, Ars-Lat —
arsenate–latrunculin A (see Sections 2.2 and 2.4 for a detailed description of treatments and quantiﬁcation).
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portion of cells with SGs gradually decreased starting at 30 min of Chx
application (data not shown). However, in cells with depolymerized
microtubules (cells treated with arsenate–nocodazole–Chx), SG
disassembly was inhibited (Fig. 8A, B, D). The portion of cells with
SGs, and the average number of SGs per cell remained constant for an
hour. The longer treatment with Chx was toxic for cells.
We compared morphology of SGs in arsenate–Chx and arsenate–
nocodazole–Chx treated cells, eitherﬁxedwithmethanol–formaldehyde
(protocol 1, see Section 2.2) and immunostained, or GFP-PABPFig. 6. SGs are positioned close to microtubules and move along them. (A) Live CHO cells exp
and time-lapse series of the movement of SGs along microtubules (frames from Video S7). E
treated with arsenate and taxol. Double immunostaining with anti-tubulin (green) and anti
arsenate for 30 min and methanol-ﬁxed. Double immunostaining with anti-tubulin (green
localized with microtubules (details a and b). Bar=5 μm.expressing and alive. At 30 min of Chx application to microtubule-
containing cell, SGs were open-work, they consisted of many subunits,
and had an irregular rough edge (Figs. 8C, 1E). Probably, SGs were
gradually torn to small pieces. In cells with disrupted microtubules SGs
had a regular shape and an even edge (Fig. 8C).
We also examined the role of actin ﬁlaments in this process and
found that in cells with depolymerized actin ﬁlaments, SGs disas-
sembled at the same rate as control cells (Fig. 8A, B). These results
were obtained for cells immunostainedwith antibodies to either eIF3a
(Fig. 8A, B) or TIA-1 (data not shown).ressing mCherry-PABP and GFP-tubulin and treated with arsenate. Overview of the cell
lapsed time is indicated. Bar=10 μm (overview) and 2 μm (time-series). (B) HeLa cell
-eIF3a antibodies (red). Bar=5 μm. (C) SGs and microtubules in CV-1 cell treated with
) and anti-eIF3 antibodies (red). Note the cluster-like shape of SGs and small SGs co-
Fig. 7. Disruption of either microtubules or actin ﬁlaments does not induce SG disassembly, and disruption of microtubules inhibits SGmotility. (A) In the upper panel: Microtubules
(green) and eIF3a (red) in control HeLa cells and cells treated with either arsenate (Ars) or arsenate–nocodazole (Ars-Noc). In the lower panel: actin ﬁlaments (green) and eIF3 (red)
in HeLa cells, control and treated with either arsenate (Ars) or arsenate–latrunculin A (Ars-LatA) (details of treatment protocols see in Section 2.2). Bar=5 μm. (B) SGs are stationary
in cells treated with arsenate–nocodazole (frames from Video S9). Elapsed time is indicated. Tracks of some SGs are shown in the rightmost picture. Bar=5 μm. (C) SGs in arsenate–
nocodazole treated cells are randomly distributed. Plot of ﬂuorescence intensity (arbitrary units) along cell radii, from cell margin to nucleus. (D) Diagram of the portion of SG-
containing cells under various experimental conditions.
368 E.S. Nadezhdina et al. / Biochimica et Biophysica Acta 1803 (2010) 361–371The assembly of SGs under arsenate treatment depends on eIF2α
phosphorylation. We studied the inﬂuence of microtubule disruption
on eIF2α phosphorylation by immunoblotting with an antibody to
phospho-eIF2α. We found that arsenate treatment increased the
amount of phospho-eIF2α in cells, while subsequent treatment with
nocodazole, Chx, and nocodazole–Chx did not cause any additional
effects (Fig. S2). Thus, the inhibitory effect of microtubule disruptionon SG disassembly is not mediated by the modulation of eIF2α
phosphorylation.
3.6. PABP dynamics in SGs is microtubule-independent
SGs are dynamic systems that exchange their components with
both the cytoplasm and polysomes. Are microtubules involved into
Fig. 8. Disruption of microtubules but not actin ﬁlaments prevents SG dissolution under Chx treatment. (A) In the upper panel: microtubules (green) and eIF3a (red) in HeLa cells
treated with either arsenate–Chx (Ars-Chx) or arsenate–nocodazole–Chx (Ars-Noc-Chx). In the lower panel: actin ﬁlaments (green) and eIF3a (red) in HeLa cells treated with either
arsenate–Chx (Ars-Chx) or arsenate–latrunculin A-Chx (Ars-LatA-Chx) (details of treatment protocols see in Section 2.2). Bar=5 μm. (B) Diagram of the portion of SG-containing
cells under various experimental conditions. (C) — SGs in cells treated with either Ars-Chx or Ars-Noc-Chx. Immunostaining with anti-eIF3a antibodies. Bar=1 μm. (D) SG number
in HeLa cells under Ars-Chx and Ars-Noc-Chx treatments.
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FRAP. Individual SGs were photobleached at 30–45 min after addition
of arsenate, and ﬂuorescence recovery was monitored for 240 s.
Bleaching the cytoplasm, outside of SGs, resulted in rapid recovery
of GFP-PABP ﬂuorescence, and the bleached region was indistinguish-
able from the control one after three seconds of recovery. However,
only 60% of GFP-PABP ﬂuorescence recovered in SGs within 4 min
after photobleaching (Fig. 9). The mobile fraction of PABP was
exchanged between SGs and the cytoplasm much more slowly than
within the cytoplasm, and the half time of the ﬂuorescence recovery
was 34 s, corroborating previous published data [10,14]. We also
performed partial photobleaching of SGs (Fig. 9). We noticed that the
time course of recovery was the same as if the entire granule was
photobleached. Additionally, the ﬂuorescence intensity of the intact
section of the granule remained constant during the recovery of the
photobleached region. This result indicates that the diffusion of GFP-
PABP inside SG is not faster than diffusion from cytoplasm to SG.
Furthermore, we performed FRAP analysis of SGs in cells with
depolymerized microtubules. The kinetics of GFP-PABP recovery was
not changed in such cells (Fig. 9). Thus, PABP dynamics in SGs was
independent of microtubules.4. Discussion
In this work, we show that SGs can move in the cytoplasm, and
their movement is supported with microtubules, not with actin
ﬁlaments. The movement of SGs is rather chaotic, but it enables SGs to
scan the intracellular area and possibly accumulate new components.
The movement also allows SGs to make contact with each other, and
fuse. The average velocity of SG movement (0.1 μm/s) correlates well
with previously reported rates of microtubule-dependent transport of
various RNPs. For example, ZBP1 and Staufen-containing mRNPs in
cardiocytes move with a velocity of 0.08–0.15 μm/s [38,39], IMP-1
protein-containing RNPs in ﬁbroblasts move at 0.12 μm/s [40], and
mRNA is transported in neurons at the rate of 0.05–0.2 μm/s [41,42].
PBs move more rapidly at 0.5 to 1.1 μm/s [30]. The proportion of
directionally moving SGs (8–10%) is similar to that of other similar
size moving organelles such as mitochondria and peroxisomes [43].
The characteristic mobility of SGs in the cytoplasm resembles that
of many other microtubule-driven cargoes which scan the cytoplasm
and demonstrate probabilistic rather that directed processive move-
ment. Such cargoes include P-bodies, which are mRNA-degrading and
mRNA storage granules (described in Section 1) [30], individual
Fig. 9. FRAP analysis of GFP-PABP dynamics in SGs of HeLa cells at 30 min after arsenate
treatment. (A) Frames of living cell imaging. Image contrast is inverted. Irradiated SGs
are pointed out with arrows. Pre — pre-bleach, 0″ — just after irradiation, then time
after irradiation is indicated. In the lower panel a part of a large SG was irradiated
(indicated with arrow). Bar=2 μm. (B) A plot of ﬂuorescence intensity of the irradiated
region after photobleaching.
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reticulum exit site compartment (ERES) [36], and even secretory
granules in resting PC12 cells [45]. A similar Dapp of ~10−3μm2/s was
found for PC12 cell secretory granules having approximately a micron
size and for ERES attached to an ER network [36,45]. The diffusion
coefﬁcient for PB mobility was 10 times higher [30]. We can
speculatively explain the difference between PB and SG movement
either by smaller PB size or by differential regulation of putative
microtubule motors bound to these organelles. Probably, PBs move
more rapidly since they are non-numerous and have to ﬁnd target
mRNAs without delay.
We speculate that SGs contain numerous microtubule motors on
their surface, which move along microtubules and ensure SG motility.
SGs can contact with many randomly oriented microtubules simulta-
neously, and suchcontacts decrease the follow-onmovement.However,
SGs cannot move without microtubules except by simple diffusion.
Since taxol treatmentdoesnot affect SG short-distancevelocity, it seems
that SGmovement is not directly related tomicrotubule dynamics.Most
likely SGs are transported with microtubule motors, and Tsai et al. [45]
recently have shown that microtubule dynein motors facilitate SG
assembly and disassembly in neurons.
What is the function of SG movement along microtubules? Our
data reveal that during SG formation, individual SGs contact and fuse
with each other; during dissociation under Chx treatment they tend to
disconnect. Probably, both fusion and splitting of SGs are facilitated by
microtubule-dependent movement. Previously, Kolobova et al. [21]
demonstrated that large SG granules were absent from nocodazole–
arsenite treated cells, while many small RNP-containing particles
(pre-SGs?) were formed under these conditions. The function of SGenlargement during stress conditions is still unclear. Perhaps larger
SGs can recruit more cell regulatory proteins and modulate the cell's
response to stress.
We also found that SGs aremost likely clustery in their structure and
are composed of smaller particles. We did not ﬁnd any evidence of
heterogeneity of these smaller particles. Our FRAP data indicate that
GFP-PABP inﬂux into SGs is independent of microtubules and that the
SG is not a compartment with increased internal diffusion of PABP.
These data support the cluster scheme of SG structure: each SG subunit
being independent and can directly exchange its contents with the
cytoplasm. We speculate that each subunit can carry microtubule
motors andmove alongmicrotubules, either aloneor stackedwith other
subunits to form a larger SG. Testing this assumption is an interesting
issue for the future research.
When this paper was under review and subsequent revision,
several works were published which demonstrated a role of
microtubules and microtubule motors in SG assembly and disassem-
bly [46–49], supporting our main conclusions.
5. Conclusions
SGs continuously move in the cytoplasm. All aspects of SGmobility
(velocity, apparent diffusion coefﬁcient, a portion of rapidly moving
and stationary granules, and intracellular distribution) depend on
microtubules: microtubule disruption inhibits SG movement, and
microtubule stabilization has complicated effect. SG rupturing during
their disassembly also depends on microtubules, and most probably it
is a result of irregular unmatchedmovement of SG parts together with
weakening interaction of SG constituents. SGs are clustered as a result
of sticking of smaller SGs.
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